Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Amare Desalegn Wolide, Belay Zawdie, Tilahun Alemayehu & Samuel Tadesse. (2016) Evaluation of serum ferritin and some metal elements in type 2 diabetes mellitus patients: comparative cross-sectional study. Diabetes, Metabolic Syndrome and Obesity 9, pages 417-424.
Read now
Read now
Vishal Kothari, John A Galdo & Suresh T Mathews. (2016) Hypoglycemic agents and potential anti-inflammatory activity. Journal of Inflammation Research 9, pages 27-38.
Read now
Read now
Andreas Liebl, Stephen Jones, Marian Benroubi, Conxa Castell, Albert Goday, Marie Aline Charles, Helen T. Smith, Claudia Nicolay & Alexander Simpson. (2011) Clinical outcomes after insulin initiation in patients with type 2 diabetes: 6-month data from the INSTIGATE observational study in five European countries. Current Medical Research and Opinion 27:5, pages 887-895.
Read now
Read now
Articles from other publishers (16)
Venkateswarlu Korthikunta, Rohit Singh, Rohit Srivastava, Jyotsana Pandey, Atul Srivastava, Upma Chaturvedi, Akansha Mishra, Arvind K. Srivastava, Akhilesh K. Tamrakar & Narender Tadigoppula. (2023) Design, synthesis, and evaluation of benzofuran-based chromenochalcones for antihyperglycemic and antidyslipidemic activities. RSC Medicinal Chemistry 14:3, pages 470-481.
Crossref
Crossref
Haoran Jiang, Miaomiao Cai, Boyuan Shen, Qiong Wang, Tongcun Zhang & Xiang Zhou. (2022) Synbiotics and Gut Microbiota: New Perspectives in the Treatment of Type 2 Diabetes Mellitus. Foods 11:16, pages 2438.
Crossref
Crossref
Seema MishraSyed S. AhmadNilam NigamPratap ShankarShravan KumarVinay KumarShalini Gupta. (2021) An observational study amongst anti-diabetic patients related to the anti-diabetic drugs prescription at tertiary care centre of northern India. Research Journal of Pharmacy and Technology, pages 6555-6557.
Crossref
Crossref
Yun Kyung Cho, Ye-Jee Kim, Yu Mi Kang, Seung Eun Lee, Joong-Yeol Park, Woo Je Lee & Chang Hee Jung. (2018) Comparison between sodium-glucose cotransporter 2 inhibitors and pioglitazone as additions to insulin therapy in type 2 diabetes patients: A systematic review with an indirect comparison meta-analysis. Journal of Diabetes Investigation 9:4, pages 882-892.
Crossref
Crossref
K Ashutosh, RM Ipseeta & R Sandeep. (2017) Assessment of Prescription Pattern of Antidiabetic Drugs in the Outpatient Department of a Tertiary Care Hospital. International Journal of Clinical Endocrinology and Metabolism 3:1, pages 001-007.
Crossref
Crossref
Shuhei Nakanishi, Mitsunobu Kubota & Rui Kishimoto. (2014) Efficacy and Safety of Patient-Led Dosage Adjustments of Insulin Glargine: A Preliminary Report of Basal-Supported Oral Therapy for Japanese Type 2 Diabetes Patients. Journal of Diabetes Mellitus 04:02, pages 77-84.
Crossref
Crossref
Hiba Ahmad Bawadi, Angela Denise Banks, Fawaz Ammari, Reema Fayez Tayyem & Shatha Jebreen. (2012) Stage of change of 6 health-related behaviors among patients with type 2 diabetes. Primary Care Diabetes 6:4, pages 319-327.
Crossref
Crossref
Andreas Liebl, Steven Jones, Alberto Goday, Marian Benroubi, Conxa Castell, Axel Haupt, Claudia Nicolay & Helen T. Smith. (2012) Clinical Outcomes After Insulin Initiation in Patients with Type 2 Diabetes: 24-Month Results from INSTIGATE. Diabetes Therapy 3:1.
Crossref
Crossref
Chi-Ting Hsieh, Tusty-Jiuan Hsieh, Mohamed El-Shazly, Da-Wei Chuang, Yi-Hong Tsai, Chiao-Ting Yen, Shou-Fang Wu, Yang-Chang Wu & Fang-Rong Chang. (2012) Synthesis of chalcone derivatives as potential anti-diabetic agents. Bioorganic & Medicinal Chemistry Letters 22:12, pages 3912-3915.
Crossref
Crossref
Naotaka Fujita, Satoru Tsujii, Hirohito Kuwata, Rie Kurokawa, Satoshi Matsunaga, Shintaro Okamura, Tsuyoshi Mashitani, Miyuki Furuya, Masako Kitatani & Hitoshi Ishii. (2012) Predictor variables and an equation for estimating HbA1c attainable by initiation of basal supported oral therapy†. Journal of Diabetes Investigation 3:2, pages 164-169.
Crossref
Crossref
I. Krass, R. Hebing, B. Mitchell, J. Hughes, G. Peterson, Y. J. C. Song, K. Stewart & C. L. Armour. (2011) Diabetes management in an Australian primary care population. Journal of Clinical Pharmacy and Therapeutics 36:6, pages 664-672.
Crossref
Crossref
Arturo R. Rolla. (2011) Progression of Type 2 Diabetes and Insulin Initiation. Journal of the National Medical Association 103:3, pages 241-249.
Crossref
Crossref
A. N. Naegeli & R. P. Hayes. (2010) Expectations about and experiences with insulin therapy contribute to diabetes treatment satisfaction in insulin-naïve patients with type 2 diabetes. International Journal of Clinical Practice 64:7, pages 908-916.
Crossref
Crossref
Kevin Niswender. (2010) Diabetes and obesity: therapeutic targeting and risk reduction - a complex interplay. Diabetes, Obesity and Metabolism 12:4, pages 267-287.
Crossref
Crossref
Irene A. Weiss, Guy Valiquette & Monica D. Schwarcz. (2009) Impact of Glycemic Treatment Choices on Cardiovascular Complications in Type 2 Diabetes. Cardiology in Review 17:4, pages 165-175.
Crossref
Crossref
Abbas Ali Mansour. (2010) Chronic Complications of Diabetes in Iraq: Experience from Southern Iraq. Clinical medicine. Endocrinology and diabetes 2, pages CMED.S3657.
Crossref
Crossref